Meldungen sortieren nach Relevanz Meldungsdatum
|
xCELLigence System Evaluated in EU Project to Replace Animal Experiments in Cosmetics Industry
, Forschung und Entwicklung, Roche Diagnostics GmbH
Roche's xCELLigence RTCA System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years...
|
Roche Diagnostics supports European Union's DETECTIVE Project to reduce Animal Testing
, Biotechnik, Roche Diagnostics GmbH
The xCELLigence RTCA System of Roche (SIX: RO, ROG; OTCQX: RHHBY) is being used in the European Union's DETECTIVE ("Detection of endpoints and biomarkers for repeated...
|
|
Functional Cell Profiling of Endogenous GPCRs using the xCELLigence System
, Biotechnik, Roche Diagnostics GmbH
Gcoupled protein receptors (GPCRs), also known as 7transmembrane proteins, constitute the single largest class of therapeutic targets for clinical and investigational...
|
4SC Publishes Preclinical Data on Vidofludimus (4SC-101) in Peer-Review Journals
, Forschung und Entwicklung, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced that two scientific...
|
|
Roche NimbleGen CGH Arrays Enable Detection of the Genomic Disorder Resulting in Diabetes
, Biotechnik, Roche Diagnostics GmbH
Chromosomal rearrangements leading to genomic disorders are often mediated by low-copy repeat regions of the genome (e.g. segmental duplications). Roche NimbleGen...
